| Resources & Energy Group Limited (REZ) ORDINARY FULLY PAID |
Materials |
$15 |
Appointment of New Chief Geologist - Rick Gordon
|
27 Aug 2024 9:42AM |
$0.028 |
$0.022 |
fallen by
21.43%
|
|
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$7 |
Kookynie Gold Project Update
|
27 Aug 2024 9:41AM |
$0.050 |
$0.022 |
fallen by
56%
|
|
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$372 |
Weekly NTA 23 August 2024
|
27 Aug 2024 9:41AM |
$1.560 |
$1.645 |
risen by
5.45%
|
|
| Bass Oil Limited (BAS) ORDINARY FULLY PAID |
Energy |
$12 |
Kiwi 1 Demonstrates Strong Initial Results from EPT
|
27 Aug 2024 9:41AM |
$0.075 |
$0.042 |
fallen by
44%
|
|
BAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Kiwi 1’s Extended Production Test (EPT) has commenced with strong initial flow rates of 4.1 million cubic feet per day (mmcfd) of gas along with 988 barrels of condensate per day at a flowing wellhead pressure of 1585 psi
- Field gas measurements indicate low impurity levels – 4.5% CO2 and no H2S
- Initial results have exceeded the Company’s expectations – in particular the hydrocarbon liquids rate, which could significantly increase the economic value of the Kiwi discovery
- Results from the EPT may see significant upside in the recoverable hydrocarbon (gas and condensate) potential of the area
- Bass Oil Limited holds a majority interest in eight permits in the Cooper Basin, including the 100% owned Worrior and Padulla oil fields and a 55% interest in a KSO in South Sumatra
- Bass Oil Limited is debt free and committed to creating value by leveraging the competitive strengths of its team, operating capability, reputation, and relationships in Australia & Indonesia
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Capital Limited (PMC) ORDINARY FULLY PAID |
Financials |
$401 |
Net Tangible Asset Backing
|
27 Aug 2024 9:40AM |
$1.445 |
$1.350 |
fallen by
6.57%
|
|
| Spirit Technology Solutions Ltd (ST1) ORDINARY FULLY PAID |
Communication Services |
$76 |
Completion of Placement and Institutional Entitlement Offer
|
27 Aug 2024 9:40AM |
$0.061 |
$0.400 |
risen by
555.74%
|
|
ST1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Spirit Technology Solutions Ltd announced the successful completion of a Placement and Institutional Entitlement Offer, raising approximately A$9.1M.
- The Placement received demand exceeding the funds sought by Spirit, and the Entitlement Offer was fully subscribed.
- Spirit will recommence trading on the ASX on 27 August 2024.
- The Retail Entitlement Offer opens on 30 August 2024 and closes on 13 September 2024.
- The Institutional Entitlement Offer raised gross proceeds of A$7,143,820.76 and included the issuance of 134,789,071 new shares.
- The Placement involved issuing 37,735,850 shares to sophisticated investors at $0.053 per share.
- The equity raise supports the acquisition and integration of Forensic IT, enhancing Spirit’s cyber capabilities.
- Retail shareholders will be able to subscribe for 1 new share for every 4.024 existing shares at the same offer price of A$0.053.
- The key dates include the announcement of the Placement and Entitlement Offer on 23 August 2024 and the settlement date on 3 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Appendix 4G and Corporate Governance Statement
|
27 Aug 2024 9:39AM |
$0.040 |
$0.027 |
fallen by
32.50%
|
|
| Peako Limited (PKO) ORDINARY FULLY PAID |
Materials |
$4 |
Peako Appoints Ryan Skeen as CEO
|
27 Aug 2024 9:38AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
PKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Peako Limited appoints Ryan Skeen as CEO.
- Ryan Skeen has extensive leadership experience in the mineral exploration sector.
- Ryan Skeen's expertise includes operations, equity capital markets, transaction structuring, and ASX compliance.
- Ryan has also provided corporate advisory services and is a Non-Executive Director of Heavy Rare Earths Limited.
- Ryan holds a Master of Applied Finance (Distinction) and a B.Bus (Financial Risk Management).
- Ryan's appointment follows strong interest in Peako's rights issue.
- Ryan's Executive Services Agreement does not have a fixed term and includes a base salary of A$200,000 plus statutory superannuation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asia Investments Limited (PAI) ORDINARY FULLY PAID |
Financials |
$370 |
Weekly Net Tangible Asset Backing
|
27 Aug 2024 9:38AM |
$0.950 |
$1.000 |
risen by
5.26%
|
|
| QPM Energy Limited (QPM) ORDINARY FULLY PAID |
Materials |
$109 |
New Agreements to Transform QPME
|
27 Aug 2024 9:38AM |
$0.030 |
$0.043 |
risen by
43.33%
|
|
QPM - Price-sensitive ASX Announcement
Full Release
Key Points
- Commercial terms agreed for new contracts to cover Townsville Power Station (TPS) dispatch rights and North Queensland Gas Pipeline (NQGP) gas transport and storage services.
- QPME and RATCH Australia Corporation to contract for dispatch rights to 100% of the capacity of TPS’s 160MW gas turbine generation unit starting from 1 July 2025.
- QPME and NQGP to contract for gas transport and storage services with significantly reduced fixed charges.
- Total annual fixed charges under the new agreements to fall by 83% compared to current contract terms, resulting in a $30+ million improvement in FY2024 financial performance.
- New agreements are expected to drive QPME's financial robustness and enable accelerated gas production growth plans.
- QPME, RAC, and NQGP plan to extend existing TPS and NQGP agreements until 31 March 2025 to maximize electricity generation during Dyno Nobel’s maintenance shutdown.
- Financial impacts include major reductions in fixed costs and better alignment with revenue generation, which helps de-risk QPME's business model.
- The new contract terms will be reflected in QPME’s FY2026 financial results.
- These agreements are seen as transformational for QPME, providing a stable and profitable business base to drive new growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lark Distilling Co. Ltd (LRK) ORDINARY FULLY PAID |
Consumer Staple |
$95 |
Application for quotation of securities - LRK
|
27 Aug 2024 9:37AM |
$0.915 |
$0.900 |
fallen by
1.64%
|
|
| X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$8 |
Entitlement Offer - confirmation of dispatch
|
27 Aug 2024 9:37AM |
$0.039 |
$0.020 |
fallen by
48.72%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$34 |
Phase 2a/b clinical trial update
|
27 Aug 2024 9:37AM |
$0.066 |
$0.160 |
risen by
142.42%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Institutional Review Board (IRB) approval received from the US Army.
- Island Pharmaceuticals begins screening and enrolling subjects for the ISLA-101 Phase 2 PROTECT clinical trial.
- The trial includes both a prophylactic and therapeutic arm.
- Dosing for the Phase 2a cohort to start in late September 2024.
- The full trial read-out expected by the end of 2024.
- US FDA approval was received for the trial protocol amendments.
- Phase 2a cohort will include 4 subjects, Phase 2b cohort will include 10 subjects.
- Prophylactic arm pre-treatment starts in late September 2024, with infection beginning in October 2024.
- Phase 2b cohort dosing expected to start in January 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$6,582 |
Climate Change Report 2024
|
27 Aug 2024 9:36AM |
$14.090 |
$12.440 |
fallen by
11.71%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$20 |
FY24 Full Year Results Announcement
|
27 Aug 2024 9:36AM |
$0.040 |
$0.027 |
fallen by
32.50%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- FY2024 revenue of US$11.1 million, up 6% from FY23
- Product revenue up 289% to US$1.2 million
- Commercial services revenue at US$9.9 million
- Gross profit increased by 19% to US$7.1 million
- Adjusted EBITDA loss improved by 28% to US$3.0 million
- Receipts from customers increased to US$16.5 million
- Positive net cash from operating activities of US$0.9 million
- US$5.0 million capital raise and full redemption of Convertible Notes
- FDA clearance for FebriDx® and Emergency Use Authorization for ViraDx®
- Strategic partnership with Hologic for development of women's health diagnostics
- Expanded distribution partnership with Henry Schein
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$88 |
Calix Limited Appendix 4G August 2024
|
27 Aug 2024 9:36AM |
$0.860 |
$0.410 |
fallen by
52.33%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - TMB
|
27 Aug 2024 9:35AM |
$0.043 |
$0.029 |
fallen by
32.56%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - TMB
|
27 Aug 2024 9:35AM |
$0.043 |
$0.029 |
fallen by
32.56%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$3 |
Placement and Non-Renounceable Entitlements Offer
|
27 Aug 2024 9:35AM |
$0.043 |
$0.029 |
fallen by
32.56%
|
|
TMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Tambourah Metals Ltd (ASX: TMB) has received binding commitments for a placement of up to A$300,000 plus an additional $75,000 from the board and management.
- The placement involves issuing up to 10.7 million fully paid ordinary shares at A$0.035 per share.
- An additional A$0.65 million is proposed to be raised through a 1-for-5 pro-rata non-renounceable entitlements offer at the same price.
- Combined, the Placement and Entitlements Offer aim to raise up to A$1.0 million.
- The new shares will include an attached 1-for-1 unquoted option exercisable at $0.045, expiring 24 months from the date of issue.
- 1.3 million Placement Shares for Directors will be subject to shareholder approval at a General Meeting in October 2024.
- The funds will be used primarily for drilling at the Company’s projects, exploration, costs of the offers, and general working capital.
- Eligible shareholders will be given the opportunity to participate in the Entitlement Offer without dilution if they subscribe fully.
- The Prospectus includes a Top-Up Offer and a Shortfall Offer for eligible shareholders and other investors.
- The Placement Shares issue price represents an 18.6% discount to the last traded price and a 16.7% discount to the 15-day VWAP.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chrysos Corporation Limited (C79) ORDINARY FULLY PAID |
Industrials |
$446 |
Chrysos FY24 Results Announcement
|
27 Aug 2024 9:34AM |
$5.460 |
$3.850 |
fallen by
29.49%
|
|
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$9 |
AusIMM Critical Minerals Conference Presentation
|
27 Aug 2024 9:34AM |
$0.120 |
$0.049 |
fallen by
59.17%
|
|
| Tlou Energy Limited (TOU) ORDINARY FULLY PAID |
Energy |
$22 |
Notice of General Meeting/Proxy Form
|
27 Aug 2024 9:34AM |
$0.035 |
$0.017 |
fallen by
51.43%
|
|
| Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$178 |
Application for quotation of securities - RNU
|
27 Aug 2024 9:34AM |
$0.090 |
$0.070 |
fallen by
22.22%
|
|
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$3 |
Appendix 3Y x 3 Directors
|
27 Aug 2024 9:34AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
| Chrysos Corporation Limited (C79) ORDINARY FULLY PAID |
Industrials |
$446 |
Full Year Results FY24
|
27 Aug 2024 9:34AM |
$5.460 |
$3.850 |
fallen by
29.49%
|
|
C79 - Price-sensitive ASX Announcement
Full Release
Key Points
- Chrysos Corporation achieved revised guidance for FY24 Revenue and EBITDA.
- Total revenue increased by 69% year-on-year (YoY) in FY24.
- Chrysos deployed 29 PhotonAssayTM units by the end of FY24.
- Four new customer contracts were signed post-period.
- Chrysos holds $61 million in cash and has $95 million in undrawn debt for sustainable growth.
- PhotonAssayTM technology was developed by CSIRO and offers faster, more accurate, and environmentally-friendly minerals analysis.
- Chrysos aims to deploy more PhotonAssayTM units globally, with a projected revenue for FY25 between $60 million to $70 million.
- FY24 EBITDA grew by 156% YoY to $9 million, driven by economies of scale.
- FY24 saw nine new PhotonAssayTM units deployed, with 50 contracted units by year-end.
- Chrysos Corporation saw significant international revenue, making up 55% of total revenue in FY24.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
